Hydrogels comprising cell adhesive peptides and methods of use thereof
US-2024376438-A1 · Nov 14, 2024 · US
US2016144069A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016144069-A1 |
| Application number | US-201615012110-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 1, 2016 |
| Priority date | Jul 31, 2008 |
| Publication date | May 26, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention features a superporous hydrogel scaffold for corneal regeneration or replacement and a method for producing the same. The superporous hydrogel is composed of a poly(2-hydroxyethyl methacrylate) (PHEMA) and poly(methyl methacrylate) (PMMA) copolymer mixed with collagen. The scaffold can be used as a suturable hybrid corneal implant or keratoprosthesis.
Opening claim text (preview).
What is claimed is: 1 . A scaffold for corneal regeneration or replacement comprising a superporous hydrogel matrix comprising a poly(2-hydroxyethyl methacrylate) (PHEMA) and poly(methyl methacrylate) (PMMA) copolymer, and a cell adhesion agent in the pores of said superporous hydrogel matrix. 2 . The scaffold of claim 1 , wherein the cell adhesion agent is collagen. 3 . The scaffold of claim 1 , wherein the pores of the superporous hydrogel matrix have an average diameter of greater than 100 μm. 4 . The scaffold of claim 1 , wherein the pores of the superporous hydrogel matrix are connected to one another to form an open channel system. 5 . The scaffold of claim 1 , wherein the equilibrium swelling capacity of the superporous hydrogel matrix ranges from 50 to 500 g/g. 6 . The scaffold of claim 1 , wherein the superporous hydrogel matrix has an ultimate tensile strength of about 80 kPa or more. 7 . The scaffold of claim 1 , wherein the copolymer is formed by dissolving 2-hydroxyethyl methacrylate (HEMA) and methylmethyacrylate (MMA) monomers in a solvent and polymerizing the monomers at a temperature below 45° C. in the presence of a pore-forming agent. 8 . A suturable implant comprising the scaffold of claim 1 , wherein said implant forms the skirt of a core-skirt keratoprosthesis for implantation into the cornea. 9 . A method for producing the scaffold of claim 1 comprising (a) dissolving 2-hydroxyethyl methacrylate (HEMA) and methylmethyacrylate (MMA) monomers in a solvent; (b) polymerizing the monomers at a temperature below 45° C. in the presence of a pore-forming agent to form a superporous hydrogel matrix; and (c) integrating a cell adhesion agent into the pores of the superporous hydrogel matrix. 10 . The method of claim 9 , wherein the cell adhesion agent is collagen.
Hydrogels or hydrocolloids · CPC title
Porous materials, {e.g. foams or sponges} · CPC title
Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment · CPC title
for reconstruction of eye parts, e.g. intraocular lens, cornea · CPC title
Mixtures of macromolecular compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.